2021 Annual Meeting - ASTRO’s First Evidence-Based Clinical Practice Guidelines on Radiation Therapy for Primary Liver Cancers

This cased-based panel session will focus on the guideline recommendations and evidentiary basis for EBRT for HCC and IHC. In ASTRO’s first primary liver cancers guideline, recommendations address the: 1) role of EBRT in the definitive/non-transplant setting in HCC and IHC; 2) role of EBRT in the neoadjuvant setting prior to surgical resection or OLT for HCC; and 3) recommended techniques, dose-fractionation regimens, and OAR dose constraints. In addition to ASTRO, the guideline task force included multidisciplinary representation from the American Society of Clinical Oncology and the Society of Surgical Oncology. The ASTRO guideline development process and the systemic review parameters for this guideline will also be briefly presented. To make the session more interactive and to frame the recommendations addressed in this guideline, we will present case conferences to solidify the understanding of the more complex and controversial topics. We will then ask the audience to respond to the SA-CME questions to confirm their comprehension of the guideline information from the presentation. 

Target Audience

The activity is designed to meet the interests of radiation oncologists, radiation oncology residents, medical oncologists, surgeons, radiation physicists, radiation therapists, radiation dosimetrists, specialists.

Learning Objectives

Upon completion of this activity, participants should be able to:

  • Identify and describe the clinically relevant clinical trials and data related to the use of EBRT for HCC and IHC for multiple clinical settings.
  • Apply new evidence-based guideline recommendations to clinical practice.
  • Discuss the limitations and knowledge gaps of EBRT and emerging technologies and treatments for HCC and IHC.
Course summary
Available credit: 
  • 1.25 Certificate of Attendance
    This activity was designated for 1.25 AMA PRA Category 1 Credit™.
  • 1.25 SA-CME

    The American Society for Radiation Oncology (ASTRO) is accredited by the Accreditation Council of Continuing Medical Education to provide continuing medical education for physicians.

    The American Society for Radiation Oncology (ASTRO) designates this for a maximum of 1.25 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    This activity meets the American Board of Radiology's criteria for a self-assessment activity in the ABR's Maintenance of Certification program. Participation in this course in combination with the successful completion of the corresponding assessment and course evaluation adheres to the guidelines established by the ABR for 1.25 self-assessment credits.

Course opens: 
08/30/2021
Course expires: 
11/30/2021
Cost:
$0.00
Rating: 
0
  • Higinia Rosa Rosa Cardenes, MD, PhD, Weill Cornell Medicine has no financial relationships with a commercial interest.
  • Aisling S. Barry, MD, Radiation Medicine Program, University Health Network and Princess Margaret Cancer Centre has no financial relationships with a commercial interest.
  • Foster D. Lasley, MD, GenesisCare has investment interest from Book: "Basic Radiotherapy Physics and Biology": Royalty and from Book: "Basic Radiotherapy Physics and Biology 2nd": Royalty.
  • Eugene J Koay, MD, PhD, Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center receives compensation from General Electric, MD Anderson Cancer Center, NIH and Phillips. Dr. Lasley has investment interest from Taylor and Francis LLC.
  • Dawn Owen, MD, PhD, Department of Radiation Oncology, Mayo Clinic receives compensation from Mayo Clinic and NIH P01 Grant.
  • Christopher L. Hallemeier, MD, Mayo Clinic, Department of Radiation Oncology and Department of Radiation Oncology, Mayo Clinic receives compensation from Mayo Clinic.
  • Smith Apisarnthanarax, MD, University of Washington Department of Radiation Oncology has no financial relationships with a commercial interest.

The person(s) above served as the developer(s) of this activity. Additionally, the Education Committee had control over the content of this activity. All relevant relationships have been mitigated.

Disclosure link: 
Committee Disclosures

The American Society for Radiation Oncology (ASTRO) is accredited by the Accreditation Council of Continuing Medical Education to provide continuing education to physicians.

ASTRO is awarded Deemed Status by the American Board of Radiology to provide SA-CME as part of Part II Maintenance of Certification. 

Available Credit

  • 1.25 Certificate of Attendance
    This activity was designated for 1.25 AMA PRA Category 1 Credit™.
  • 1.25 SA-CME

    The American Society for Radiation Oncology (ASTRO) is accredited by the Accreditation Council of Continuing Medical Education to provide continuing medical education for physicians.

    The American Society for Radiation Oncology (ASTRO) designates this for a maximum of 1.25 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    This activity meets the American Board of Radiology's criteria for a self-assessment activity in the ABR's Maintenance of Certification program. Participation in this course in combination with the successful completion of the corresponding assessment and course evaluation adheres to the guidelines established by the ABR for 1.25 self-assessment credits.

Price

Cost:
$0.00
Please login or register to take this course.

Policies: 
    • No refunds, extensions or substitutions will be made for those registrants who, for any reason, were unable to attend or were tardy for the session.
    • No credits will be granted and no refunds, exchanges or transfers will be given to those who do not pass.
    • ASTRO staff cannot make modifications to your submitted materials.
 

Required Hardware/software

One of the two latest versions of Google Chrome, Mozilla Firefox, Internet Explorer or Safari.